Select your country or region
- Africa
- America
- Asia
- Europe
- Oceania
- Australia
- New Zealand
- Andorra
- Austria
- Czech Republic
- Denmark
- Finland
- France
- Germany
- Gibraltar
- Iceland
- Ireland
- Italy
- Norway
- Poland
- Portugal
- San Marino
- Slovakia
- Spain
- Sweden
- Switzerland
- UK
- Vaticano
- Argentina
- Aruba
- Bolivia
- Brazil
- Canada
- Chile
- Colombia
- Costa Rica
- Curacao
- Dominican Republic
- Ecuador
- El Salvador
- Guatemala
- Honduras
- Mexico
- Nicaragua
- Panama
- Paraguay
- Peru
- Surinam
- Trinidad and Tobago
- USA
- Uruguay
- Venezuela
- Bahrain
- Bangladesh
- Brunei
- Cambodia
- China
- Hong Kong SAR
- India
- Indonesia
- Iraq
- Japan
- Jordan
- Kuwait
- Laos
- Lebanon
- Malaysia
- Oman
- Pakistan
- Philippines
- Qatar
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Taiwan, China
- Thailand
- UAE
- Vietnam
- Yemen
- Angola
- Cape Verde
- Egypt
- Guinea-Bissau
- Mozambique
- São Tomé and Príncipe
Grifols Nordic AB
Grifols Nordic was established in 2010. Based in Stockholm, we cover the Denmark, Finland, Iceland, Norway and Sweden markets.
We offer a limited portfolio of products and services from the Bioscience, Diagnostic and Hospital divisions. Safety and quality are our top priorities as we deliver on our mission: improving the health and well-being of people around the world.
Sveavägen 166
113 46 Stockholm
SWEDEN
Contact information
Tel: +46 (0) 8 441 89 50
Mail: infonordic@grifols.com
Notification of adverse reactions
To report an adverse drug reaction click here
Do you want to know more about one of the leading healthcare companies? Here you will find all the information about Grifols and our commitment to improving the health and well-being of people around world.